HomeNews

News

Reflecting on 2024 Following an Ovarian Most cancers Analysis

It's early December, my home is adorned, and I can be making my Chex Mixes quickly. Add to that, cookies! However first, earlier...

High 5 Tales from the 2024 San Antonio Breast Most cancers Symposium

Listed below are 5 high tales that had been coated throughout the 2024 San Antonio Breast Most cancers Symposium. Research outcomes offered at...

How Monjuvi Plus Revlimid, Rituxan Work to Deal with Follicular Lymphoma

Amongst sufferers with relapsed or refractory follicular lymphoma (FL), the therapy mixture of Monjuvi (tafasitamab-cxix) plus Revlimid (lenalidomide) and Rituxan (rituximab) has been...

Monjuvi Mixture Could Enhance Survival in Follicular Lymphoma

Monjuvi plus Revlimid and Rituxan demonstrated improved progression-free survival for sufferers with relapsed or refractory follicular lymphoma, as introduced on the 2024 ASH...

High 5 Most cancers Vaccine Tales from 2024

Listed below are the highest 5 most cancers vaccine tales CURE® has lined throughout 2024. This has been a yr of great promise...

Hot Topics